AAM
AXON

Advisors Asset Management’s Axon Enterprise AXON Stock Holding History

Advisors Asset Management’s Portfolio AXON Stock Details AXON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Sell
7,271
-3,024
-29% -$1.27M 0.06% 405
2026
Q1 		$4.37M Sell
10,295
-2,313
-18% -$1.2M 0.07% 366
2025
Q4 		$7.16M Sell
12,608
-4,980
-28% -$3.09M 0.12% 216
2025
Q3 		$12.6M Sell
17,588
-2,132
-11% -$1.62M 0.21% 86
2025
Q2 		$16.3M Sell
19,720
-3,581
-15% -$2.44M 0.29% 55
2025
Q1 		$12.3M Sell
23,301
-6,012
-21% -$3.52M 0.23% 85
2024
Q4 		$17.4M Sell
29,313
-1,129
-4% -$614K 0.32% 52
2024
Q3 		$12.2M Buy
30,442
+850
+3% +$293K 0.22% 90
2024
Q2 		$8.71M Buy
29,592
+180
+0.6% +$53.7K 0.17% 142
2024
Q1 		$9.2M Buy
29,412
+3,259
+12% +$906K 0.18% 132
2023
Q4 		$6.76M Buy
26,153
+7,503
+40% +$1.69M 0.14% 176
2023
Q3 		$3.71M Buy
18,650
+2,965
+19% +$583K 0.08% 324
2023
Q2 		$3.06M Buy
15,685
+3,741
+31% +$775K 0.06% 377
2023
Q1 		$2.69M Buy
11,944
+3,429
+40% +$682K 0.05% 421
2022
Q4 		$1.41M Buy
8,515
+1,268
+17% +$200K 0.03% 611
2022
Q3 		$839K Sell
7,247
-276
-4% -$31.3K 0.02% 786
2022
Q2 		$701K Buy
7,523
+499
+7% +$52.8K 0.01% 861
2022
Q1 		$967K Buy
7,024
+1,960
+39% +$269K 0.01% 815
2021
Q4 		$795K Buy
5,064
+525
+12% +$88.1K 0.01% 883
2021
Q3 		$794K Sell
4,539
-3,217
-41% -$584K 0.01% 890
2021
Q2 		$1.37M Sell
7,756
-2,020
-21% -$297K 0.02% 717
2021
Q1 		$1.39M Sell
9,776
-3,660
-27% -$571K 0.02% 712
2020
Q4 		$1.65M Sell
13,436
-4,173
-24% -$479K 0.03% 630
2020
Q3 		$1.6M Sell
17,609
-1,083
-6% -$94.2K 0.03% 554
2020
Q2 		$1.83M Buy
18,692
+90
+0.5% +$7.28K 0.04% 489
2020
Q1 		$1.32M Sell
18,602
-705
-4% -$52.8K 0.03% 545
2019
Q4 		$1.41M Buy
19,307
+850
+5% +$53.8K 0.02% 648
2019
Q3 		$1.05M Buy
18,457
+5,362
+41% +$338K 0.02% 742
2019
Q2 		$841K Buy
13,095
+3,471
+36% +$226K 0.02% 844
2019
Q1 		$524K Buy
9,624
+5,236
+119% +$268K 0.01% 986
2018
Q4 		$192K Buy
+4,388
New +$228K ﹤0.01% 1206

Other funds holding AXON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisors Asset Management's AXON Position: Q2 2026 in Review

Advisors Asset Management reduced its Axon Enterprise (AXON) stake by 29% in Q2 2026, selling an estimated $1.27M and leaving 7,271 shares worth $4.08M. The position accounts for 0.06% of the portfolio, ranked #405.

Advisors Asset Management first reported a position in AXON in Q4 2018 and has held it in 31 quarters since. The position peaked at $17.4M in Q4 2024. 1,124 funds tracked by Wall St. Rank hold AXON as of Q2 2026.

  • Advisors Asset Management held 7,271 shares of Axon Enterprise worth $4.08M as of Q2 2026.
  • Advisors Asset Management sold 3,024 Axon Enterprise shares in Q2 2026, an estimated $1.27M.
  • Axon Enterprise made up 0.06% of Advisors Asset Management's portfolio in Q2 2026, its #405 holding.
  • Advisors Asset Management first reported a position in Axon Enterprise in Q4 2018 and has held it in 31 quarters since.
  • Advisors Asset Management's Axon Enterprise position peaked at $17.4M in Q4 2024.
  • 1,124 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.